CUMBERLAND PHARMACEUTICALS
Cumberland Pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. Cumberland is dedicated to providing high quality products which address unmet medical needs.
CUMBERLAND PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care
Founded:
1999-01-01
Address:
Nashville, Tennessee, United States
Country:
United States
Website Url:
http://www.cumberlandpharma.com
Total Employee:
51+
Status:
Active
Contact:
6152550094
Email Addresses:
[email protected]
Technology used in webpage:
SPF SSL By Default Google Font API Domain Not Resolving Apache Euro Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS
Similar Organizations
Allos Therapeutics
Allos Therapeutics is a biopharmaceutical company that develops and commercializes anti-cancer therapeutics.
Nutraceutix
Nutraceutix specialty pharmaceutical company, develops and commercializes prescription, over-the-counter, and nutritional products.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-01-04 | SANCUSO | SANCUSO acquired by Cumberland Pharmaceuticals | N/A |
Official Site Inspections
http://www.cumberlandpharma.com Semrush global rank: 4.91 M Semrush visits lastest month: 1.76 K
- Host name: ssl-pool.wc1.lan3.stabletransit.com
- IP address: 184.106.55.138
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Cumberland Pharmaceuticals"
Management Team – Cumberland Pharmaceuticals
Mr. Hamm has over 25 years of finance, accounting and operations experience in several industries, with a majority in health care. He previously held the positions of Chief Operating Officer and Chief Financial Officer, Pharmacy at …See details»
Contact – Cumberland Pharmaceuticals
[email protected]. Business Development [email protected]. Wholesaler Customer Service Phone: 877.274.7200 …See details»
Cumberland Pharmaceuticals - LinkedIn
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes FDA-approved branded prescription products. We are the largest publicly listed ...See details»
Corporate Update - Cumberland Pharmaceuticals, Inc.
Please see our corporate website at www.cumberlandpharma.com for links to our product websites for full prescribing and safety information on our brands and for our SEC filings that …See details»
Cumberland Pharmaceuticals - Crunchbase Company Profile
Contact Email [email protected] Phone Number 6152550094 Cumberland Pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently …See details»
Investor Relations | Cumberland Pharmaceuticals, Inc.
[email protected]. Investor Relations. [email protected]. Business Development. [email protected]. Wholesaler Customer …See details»
Annual Reports - Cumberland Pharmaceuticals, Inc.
[email protected]. Investor Relations. [email protected]. Business Development. [email protected]. Wholesaler Customer …See details»
Cumberland Pharmaceuticals - Overview, News & Similar
Aug 13, 2024 Cumberland Pharmaceuticals contact info: Phone number: (615) 255-0068 Website: www.cumberlandpharma.com What does Cumberland Pharmaceuticals do? …See details»
EARLY 2025 MILESTONES – Cumberland Pharmaceuticals
Cumberland’s business strategy has been to acquire and commercialize a portfolio of branded pharmaceuticals that we can grow through our dedicated sales organization domestically and …See details»
Cumberland Pharmaceuticals Company Overview, Contact Details ...
Aug 15, 2022 | cumberlandpharma.com. Cumberland Pharmaceuticals Inc. hired Martin Brown Jr. as Board of Directors on Jul 19th '22. Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ), a …See details»
Cumberland Pharmaceuticals Company Profile | Management and …
Www.cumberlandpharma.com Cumberland Pharmaceuticals Profile and History Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, …See details»
Cumberland Pharmaceuticals Inc Company Profile - Overview
Website www.cumberlandpharma.com Telephone 1 615 2550068. No of Employees 91. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange CPIX (NASD) Revenue (2023) …See details»
Cumberland Pharmaceuticals - Craft
Oct 29, 2024 Cumberland Pharmaceuticals has 5 employees at their 1 location and $39.55 m in annual revenue in FY 2023. See insights on Cumberland Pharmaceuticals including office …See details»
Financial Information | Cumberland Pharmaceuticals, Inc.
Cumberland Pharmaceuticals Inc. 1600 West End Avenue, Suite 1300, Nashville, Tennessee 37203See details»
Our Strategy – Cumberland Pharmaceuticals
Our strategy involves maximizing the potential of our existing brands, while continuing to build a portfolio of differentiated products. Our clinical team is developing a pipeline of new product …See details»
News Release - Cumberland Pharmaceuticals, Inc.
Dec 31, 2022 2022 highlights include its acquisition of Sancuso ® and move to new headquarters. NASHVILLE, Tenn., March 7, 2023 /PRNewswire/ -- Cumberland …See details»
Novartis receives third FDA approval for oral Fabhalta® (iptacopan ...
6 days ago Novartis receives third FDA approval for oral Fabhalta ® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G). Phase III study showed sustained …See details»
Press Release - investor.cumberlandpharma.com
Mar 4, 2025 Cumberland ended the year with $76 million in total assets – including $18 million in cash, $53 million in liabilities and $23 million of shareholders' equity. "2024 was a …See details»
News – Cumberland Pharmaceuticals
Mar 12, 2025 Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart DiseaseSee details»
Press Release - investor.cumberlandpharma.com
Nov 7, 2024 The World Health Organization (" WHO ") issued a new report that found that antimicrobial resistance is becoming an urgent global health and socioeconomic crisis. …See details»